Research Progress of Artemisinin and Its Derivatives in Female Reproductive System Malignancies
Medical Diagnosis · 2026 · 16 (04) · 436-448
DOI: 10.12677/md.2026.164058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Diagnosis, 2026. Verfasst von 晓 王. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
青蒿素及其衍生物(Artemisinin and its derivatives, ARTs)目前主要应用于疟疾治疗。近年来,其抗肿瘤活性受到了广泛关注。多项研究已经证实ARTs能够通过抑制肿瘤细胞增殖、诱导细胞凋亡、阻滞细胞周期以及调节肿瘤微环境等多种途径,对乳腺癌、卵巢癌、宫颈癌和子宫内膜癌等女性生殖系统恶性肿瘤发挥抗肿瘤作用。并且ARTs能够逆转化疗耐药,与常规抗癌药物产生协同效应,这为临床耐药患者的治疗提供了新的思路。本文主要对青蒿素及其衍生物在女性生殖系统恶性肿瘤治疗中的研究进展进行综述,以期为女性生殖系统恶性肿瘤的治疗提供新思路。Artemisinin and its derivatives (ARTs) are currently primarily used in the treatment of malaria. In recent years, their antitumor activity has received widespread attention. Numerous studies have confirmed that ARTs can exert antitumor effects against female reproductive system malignancies, including breast cancer, ovarian cancer, cervical cancer, and endometrial cancer, through multiple mechanisms such as inhibiting tumor cell proliferation, inducing apoptosis, arresting the cell cycle, and regulating the tumor microenvironment. Moreover, ARTs can reverse chemotherapy resistance and produce synergistic effects with conventional anticancer drugs, providing new ideas for the treatment of clinically drug-resistant patients. This review summarizes the research progress of artemisinin and its derivatives in the treatment of female reproductive system malignancies, aiming to provide new insights for the treatment of these cancers.
Zitieren
APA
王, 晓. (2026). Research Progress of Artemisinin and Its Derivatives in Female Reproductive System Malignancies. Medical Diagnosis, 16(04), 436-448. https://doi.org/10.12677/md.2026.164058
Vancouver
王 晓. Research Progress of Artemisinin and Its Derivatives in Female Reproductive System Malignancies. Medical Diagnosis. 2026;16(04):436-448. doi:10.12677/md.2026.164058
BibTeX
@article{2026,
author = {王, 晓},
title = {Research Progress of Artemisinin and Its Derivatives in Female Reproductive System Malignancies},
journal = {Medical Diagnosis},
year = {2026},
volume = {16},
number = {04},
pages = {436--448},
doi = {10.12677/md.2026.164058}
}
EUVIMED